Rockwell Medical gains on supply deal with Concerto Renal Services
** Shares of dialysis chemicals supplier Rockwell Medical
Inc RMTI.O rise ~16% to $2.49
** Co establishes three-year multi-million dollar deal with
Concerto Renal Services to be sole supplier of acid and
bicarbonate concentrates which are used for dialysis patients
** Co has a market capitalization of $25 mln
** Stock has more than doubled its valuation YTD
(Reporting by Anirban Chakroborti in Bengaluru)
((Anirban.Chakroborti@thomsonreuters.com;))
Recent news on Rockwell Medical
See all newsRockwell Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Rockwell Medical Q2 sales rise 11% on new customers
Rockwell Medical Inc expected to post a loss of 23 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:30 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM